OakChart

Canopy Growth Corp

CGCHealthcare·Drug Manufacturers - Specialty & Generic·Canada·Micro·NASD·Nov 11 • 2:31 PM ET

0.6016+0.0092 (1.55%)
2026-11-11 20:32 CET
Market cap
250.79 USD m
Revenue, TTM
222.15 USD m
Net income, TTM
-197.31 USD m
Free cash flow, TTM
-58.17 USD m
EPS diluted, TTM
-0.52
P/E
-
Compare

Price

CGC against its 20, 50 and 200-day averages
2050200beatmiss
0.600.801.001.208.2M16.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CGCclose 0.6020-day 0.6850-day 0.81200-day 0.980.60

74.7% under the 52-week high of 2.38 on 18 Dec 2025. 52-week low 0.58 on 6 Nov 2026. Last 15 sessions, 31.5% high to low

Profile

CGC
52-week range, 1% of the way up
0.582.38

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. It operates through the following segments: Cannabis, Storz and Bickel. The Cannabis segment includes the global production, distribution and sale of a diverse range of cannabis and cannabis-related products. The Storz and Bickel segment produces and sells vaporizers. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Employees1128
IPOApr 07, 2014
Beta0.87
ATR, 14d0.05
Rel volume0.74
Short float7.51%
Insider own0.56%
Inst own7.80%

Snapshot

6 groups

Valuation

Index-
Market Cap254.69M
Enterprise Value224.34M
Income-197.31M
Sales222.15M
Book/sh1.08
Cash/sh0.54
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees1128
IPOApr 07, 2014

Ratios

P/E-
Forward P/E-
PEG-
P/S1.15
P/B0.56
P/C1.11
P/FCF-
EV/EBITDA-
EV/Sales1.01
Quick Ratio2.20
Current Ratio2.82
Debt/Eq0.43
LT Debt/Eq0.34
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.52
EPS next Y-0.10
EPS next Q-0.02
EPS this Y79.76%
EPS next Y24.80%
EPS next 5Y52.88%
EPS past 3/5Y77.14% 55.23%
Sales past 3/5Y-6.50% -13.01%
EPS Y/Y TTM73.50%
Sales Y/Y TTM11.47%
EPS Q/Q-1497.67%
Sales Q/Q20.04%
EarningsNov 06 BMO
EPS/Sales Surpr.-156.88% -2.03%

Ownership

Insider Own0.56%
Insider Trans-12.30%
Inst Own7.80%
Inst Trans-0.12%
ROA-26.07%
ROE-39.98%
ROIC-32.04%
Gross Margin17.46%
Oper. Margin-25.51%
Profit Margin-88.82%
SMA20-11.09%
SMA50-25.98%
SMA200-38.57%
Trades-

Technical

Shs Outstand423.35M
Shs Float420.98M
Short Float7.51%
Short Ratio10.71
Short Interest31.62M
52W High2.38 -74.72%
52W Low0.58 3.56%
Volatility9.93% 6.73%
ATR (14)0.05
RSI (14)31.75
Beta0.87
Rel Volume0.74
Avg Volume2.95M
Volume1,715,355

Performance

Perf Week-19.97%
Perf Month-21.10%
Perf Quarter-40.44%
Perf Half Y-44.81%
Perf YTD-47.23%
Perf Year-49.87%
Perf 3Y-88.45%
Perf 5Y-99.56%
Perf 10Y-99.13%
Recom2.50
Target Price1.35
Prev Close0.59
Price0.60
Change %1.55%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Mar 27, 2026InitiatedCCanaccord GenuityBuy
Nov 10, 2025UpgradeTThe Benchmark CompanySell → Hold
Apr 04, 2023UpgradeBBernsteinUnderperform → Mkt Perform
Nov 02, 2022InitiatedBBernsteinUnderperform$1.50+149.3%
Oct 26, 2022UpgradeCCanaccord GenuitySell → Hold
Jun 08, 2022DowngradeBBMO Capital MarketsMarket Perform → Underperform
Mar 22, 2022DowngradeBBarclaysEqual Weight → Underweight
Dec 22, 2021DowngradeBBofA SecuritiesNeutral → Underperform
Dec 20, 2021DowngradePPiper SandlerNeutral → Underweight$11 → $7+1,063.6%
Dec 07, 2021InitiatedWWells FargoUnderweight$8+1,229.8%

Peers

Mkt cap
TickerCompanyMkt cap
TLRYTilray Brands Inc390.90M
ACBAurora Cannabis Inc332.98M
CRONCronos Group Inc1.27B
OGIOrganigram Global Inc120.30M
TRLVTrulieve Cannabis Corp2.17B
GLASGlass House Brands Inc151.38M
SNDLSNDL Inc341.87M
INCRIntercure Ltd50.58M
VFFVillage Farms International Inc329.04M
HITIHigh Tide Inc227.75M

Insider trading

latest 14 of 21
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Yanofsky TheresaDirectorSep 28 '26Sale0.9314,92013,828131,495Sep 30 04:32 PM
Lazzarato David AngeloDirectorSep 28 '26Sale0.9322,38020,742189,479Sep 30 04:31 PM
BAYERN JOSEPHDirectorSep 28 '26Sale0.933,0962,869142,031Sep 30 04:30 PM
ATKINS M SHANDirectorSep 28 '26Sale0.933,0962,869143,421Sep 30 04:30 PM
Stewart Thomas CarltonSee RemarksSep 17 '26Sale0.9325,75523,952588,412Sep 17 06:44 PM
Gedeon ChristelleSee RemarksAug 24 '26Sale1.4713,34419,616692,162Aug 25 05:41 PM
Stewart Thomas CarltonSee RemarksAug 24 '26Sale1.472,2313,280614,167Aug 25 05:40 PM
BAYERN JOSEPHDirectorJun 26 '26Sale0.923,1972,953145,127Jun 29 04:16 PM
Yanofsky TheresaDirectorJun 26 '26Sale0.9215,05413,905146,415Jun 29 04:16 PM
ATKINS M SHANDirectorJun 26 '26Sale0.923,1972,953146,517Jun 29 04:15 PM
Lazzarato David AngeloDirectorJun 26 '26Sale0.9222,67420,944211,859Jun 29 04:15 PM
Stewart Thomas CarltonSee RemarksJun 17 '26Sale0.979,2859,045616,398Jun 22 04:32 PM
Gedeon ChristelleSee RemarksJun 17 '26Sale0.9758,99457,466705,506Jun 22 04:31 PM
Mongeau LucChief Executive OfficerJun 17 '26Sale0.97135,231131,7291,723,913Jun 22 04:28 PM

Held by

AUM
TickerCompanyAUM
MJAmplify Alternative Harvest ETFAUM: 98.28M
YOLOAdvisorShares Pure Cannabis ETFAUM: 30.85M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q22026-11-06-0.071-0.028-0.07157.7058.895
2026Q12026-08-07-0.022-0.042-0.02558.1958.984
2025Q42026-06-15-0.286-0.074-0.29350.9854.134
2025Q32026-02-06-0.132-0.041-0.13054.6751.114
2025Q22025-11-07-0.007-0.113-0.00447.3851.394
2025Q12025-08-08-0.160-0.168-0.15952.4447.004
2024Q42025-05-30-1.040-0.328-0.99647.3049.886
2024Q32025-02-07-0.776-0.333-0.79052.2449.186
2024Q22024-11-08-1.065-0.365-1.08345.3346.856
2024Q12024-08-09-1.166-0.333-1.17348.2351.128
2023Q42024-05-30-0.754-0.327-0.76553.2553.929
2023Q32024-02-09-1.946-0.369-1.92058.3054.368
2023Q22023-11-09-3.107-1.150-3.22850.2953.518
2023Q12023-08-09-0.522-1.339-0.51681.1268.276
2022Q42023-06-22-9.705-1.546-10.54866.3772.177
2022Q32023-02-09-4.025-1.637-3.96375.4386.659

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-27.492-41.704-28.528288.51309.08
2020FY-39.022-24.703-35.502454.82444.02
2021FY-6.0353.767-6.319407.79422.98
2022FY-53.605-44.609-53.438305.48316.56
2023FY-6.430-4.990-6.516217.38236.53
2024FY-4.044-3.374-3.402195.64196.96
2025FY-0.630-0.334-0.630203.66208.48
2026FY--0.127--239.2
2027FY--0.096--257.1
2028FY--0.066--273.24
2029FY--0.064--279.46
2030FY--0.061--294.83

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q3S2026-11-0970463.6259.7765.84
2026Q3S2026-11-0670363.9459.7766.20
2026Q3S2026-10-2770064.5760.4666.36
2026Q3S2026-10-2170064.6460.4666.36
2026Q3S2026-08-2973164.6460.4666.36
2026Q3S2026-08-1074364.6460.4666.36
2026Q3S2026-08-0774364.6260.3266.36
2026Q3S2026-07-2272464.9460.3270.91
2026Q3S2026-07-2072464.9660.3270.91
2026Q3S2026-06-1972465.0160.3270.91
2026Q3S2026-06-1562465.5060.3270.91
2026Q3S2026-06-1060068.4758.8073.24
2026Q3S2026-06-0561068.4758.8073.24
2026Q3S2026-05-3061068.5258.8073.24

Estimate history

EPS, annual-3.09-21.021-28.528-35.502-6.319-53.438-6.516-3.402-0.638-0.5166
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.083-0.79-0.996-0.159-0.004-0.13-0.293-0.025-0.069
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual60.704172.539299.653413.366406.992251.914220.299193.391205.921222.15
Period201720182019202020212022202320242025TTM
Sales, quarterly46.18253.4645.32352.09248.42253.45951.93958.62958.126
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual19.93233.75135.01138.28839.44251.73191.116183.865422.068423.353
Period201720182019202020212022202320242025MRQ
Shares, quarterly93.864129.153183.865205.147332.381368.285422.068423.022423.353
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue222.15205.92193.39220.30251.91406.99413.37299.65172.54
Cost of Goods Sold Incl. D&A183.37169.87153.62182.17326.28521.52400.02377.37167.40
Gross Profit38.7836.0539.7738.13-74.37-114.5313.34-77.715.13
Selling, General and Administrative Excl. Other95.4588.9487.50133.73224.81354.96436.86692.41473.23
Research and Development-1.891.973.4216.4225.8043.5446.4511.62
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-56.67-52.89-47.73-95.60-299.18-469.49-423.52-770.12-468.09
Interest Expense32.6927.6353.6178.1195.3782.906.405.0514.04
Unusual Expense119.78116.82269.55192.931,956.75-289.24804.68406.59131.67
Net Income Before Taxes-198.33-190.21-365.05-349.45-2,332.90-270.77-1,233.58-1,085.56-531.44
Income Taxes-1.020.025.139.14-4.33-7.14-9.94-91.393.13
Consolidated Net Income-197.31-190.22-370.18-358.59-2,328.57-263.63-1,263.44-1,042.58-542.77
Net Income From Continuing Operations-197.31-190.22-370.18-358.59-2,327.14-247.27-1,319.48-992.90-561.26
Net Income-197.31-190.22-365.85-487.29-2,478.04-247.27-1,319.48-992.90-561.26
EPS (Recurring)-0.27-0.36-1.65-4.71-23.90-11.49-20.35-20.35-17.57
EPS (Basic, Before Extraordinaries)-0.52-0.64-3.40-6.52-53.44-6.32-35.50-28.53-21.02
EPS (Diluted)-0.52-0.64-3.40-6.52-53.44-6.32-35.50-28.53-21.02
EBITDA-29.33-26.50-16.73-56.17-238.68-378.24-327.39-676.18-432.33
Non-Operating Income (Expense)10.817.145.8417.1818.40-7.621.0196.2082.35
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense285.412.44-2.398.3115.1229.9450.66176.89153.21
Price To Sales Ratio1.701.370.512.933.227.3028.8716.7066.97
Gross Margin17.4617.5120.5717.31-29.52-28.143.23-25.932.98
Operating Margin-25.51-25.69-24.68-43.39-118.76-115.36-102.46-257.00-271.30
Net Margin-88.82-92.38-189.18-221.19-983.68-60.75-319.20-331.35-325.30
Shares Outstanding423.35422.07183.8791.1251.7339.4438.2935.0133.75
Market Capitalization250.79250.79140.90786.32905.282,989.7212,263.495,048.6314,513.88

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue58.1358.6351.9453.4648.4252.0945.3253.46
Cost of Goods Sold Incl. D&A45.8646.7749.2541.4936.1743.0142.2440.53
Gross Profit12.2611.862.6911.9612.259.083.0812.93
Selling, General and Administrative Excl. Other26.8124.5622.7221.3624.1621.986.1426.88
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-14.55-12.70-20.03-9.40-11.91-12.90-3.06-13.94
Interest Expense9.309.168.985.266.397.0310.7211.99
Unusual Expense7.44-8.9188.9232.32-16.0710.70141.9757.65
Net Income Before Taxes-29.64-10.62-113.42-44.65-1.03-29.78-154.14-86.94
Income Taxes-0.57-0.09-0.620.260.160.210.230.23
Consolidated Net Income-29.07-10.53-112.80-44.91-1.19-29.99-154.37-87.17
Net Income From Continuing Operations-29.07-10.53-112.80-44.91-1.19-29.99-154.37-87.17
Net Income-29.07-10.53-112.80-44.91-1.19-29.99-153.88-87.17
EPS (Recurring)-0.06-0.04-0.13-0.06-0.05-0.12-0.35-0.42
EPS (Basic, Before Extraordinaries)-0.07-0.02-0.29-0.13-0.00-0.16-1.00-0.79
EPS (Diluted)-0.07-0.02-0.29-0.13-0.00-0.16-1.00-0.79
EBITDA-7.15-5.45-13.72-3.01-5.20-5.914.93-6.57
Non-Operating Income (Expense)1.652.324.512.331.200.851.60-3.35
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense211.6972.151.070.501.15-0.06-2.91
Price To Sales Ratio1.701.931.771.972.011.180.741.50
Gross Margin21.0920.235.1822.3825.3017.436.8024.19
Operating Margin-25.03-21.66-38.56-17.58-24.59-24.76-6.75-26.08
Net Margin-50.01-17.96-217.17-84.02-2.46-57.57-339.51-163.05
Shares Outstanding423.35423.02422.07368.28332.38205.15183.87129.15
Market Capitalization250.79397.45355.07390.11455.51221.32140.90270.37

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments264.9395.80155.75580.031,107.941,838.361,403.763,395.63250.71
Short Term Receivables26.0036.6738.3150.5869.3273.5463.3480.0716.62
Inventories79.1966.9657.1261.50163.76292.78274.76142.2791.49
Other Current Assets9.275.2423.11103.8842.1353.4959.7864.1414.87
Total Current Assets379.40204.67274.29795.991,383.142,258.181,801.653,682.12373.69
Net Property, Plant & Equipment226.79203.94236.54348.23754.80854.941,071.28820.64235.55
Total Investments and Advances77.40125.05323.39419.92640.75563.53221.38356.16175.74
Intangible Assets106.1292.58108.84182.001,696.651,748.441,707.831,532.94323.02
Deferred Tax Assets---14.5317.6165.552.7734.8231.41
Other Assets11.9411.3817.8356.5712.283.9513.1319.396.47
Total Assets801.64637.62960.891,802.714,505.235,494.584,818.036,411.251,145.87
Short Term Debt Incl. Current Port. of LT Debt21.9014.4588.02453.4937.8941.2839.8777.631.21
Accounts Payable24.9518.1321.1923.5251.4653.5286.69141.4135.82
Other Current Liabilities66.6839.0164.24116.9581.33131.42168.9389.1034.36
Total Current Liabilities113.5371.60173.45593.96170.68226.22295.49308.1471.38
Long Term Debt177.82227.62405.61612.081,275.231,326.57399.81630.465.32
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities5.88--14.7930.4182.5633.1078.6657.42
Other Liabilities4.555.9011.9835.08130.37977.56451.82100.3147.43
Total Liabilities301.77305.11591.041,241.121,606.692,612.921,180.231,117.56181.56
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity499.87332.51369.75560.412,869.042,770.273,433.005,075.21898.80
Total Shareholders Equity499.87332.51369.75560.412,869.042,770.273,433.005,075.21898.80
Accumulated Minority Interest0.000.000.101.1729.50111.40204.80218.4865.51
Total Equity499.87332.51369.86561.592,898.532,881.663,637.815,293.69964.31
Total Liabilities & Stockholders Equity801.64637.62960.891,802.714,505.235,494.584,818.036,411.251,145.87
Book Value Per Share1.181.814.0610.8372.7472.3598.05150.3745.09
Tangible Book Value Per Share0.931.302.867.3229.7226.6949.27104.9528.89
Full-Time Employees1,1289601,0291,6213,1513,2594,4342,9171,033
Price to Book Ratio0.550.291.731.621.044.431.472.746.43
Return on Assets-26.43-46.32-25.82-73.78-4.95-25.59-17.44-14.85-6.46
Return on Equity-45.38-105.43-77.10-135.71-8.77-42.54-22.99-18.79-7.95
Return on Invested Capital-28.07-65.32-62.85-211.35-5.97-32.21-25.91-9.84-6.06
Quick Ratio2.641.921.251.247.148.695.1711.493.95
Current Ratio3.342.861.581.348.109.986.1011.955.24

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-199.80-190.22-370.18-358.59-2,328.57-263.63-1,263.44-1,042.58-542.77
Depreciation27.4226.3931.0039.4260.5091.2596.1293.9435.77
Other Funds (Non Cash)102.8397.84244.62138.821,799.77-394.86598.56749.32196.73
Funds from Operations-70.19-65.98-89.43-180.35-468.30-567.25-594.89-303.25-308.97
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital16.7319.81-29.74-28.6846.84131.95242.71-277.34-98.88
Cash from Operating Activities-53.46-46.17-119.16-209.03-421.46-435.30-352.18-580.59-407.85
Capital Expenditures-6.27-4.31-8.11-2.96-7.90-38.37-131.68-542.47-547.95
Net Assets From Acquisitions-30.28-30.05-5.010.000.00-11.92-153.33-671.81-267.66
Sale of Fixed Assets and Businesses1.080.003.55113.5021.57115.9834.720.000.00
Purchase or Sale of Investments-50.7213.75-56.7357.98329.16132.85-426.90971.43-1,645.07
Purchase of Investments-51.220.00-68.54-0.26-50.76-302.59-432.20-101.24-1,645.07
Sale Or Maturity of Investments0.5013.7511.8158.23379.92435.445.291,072.670.00
Other Uses0.000.000.00-5.71-18.18-14.46-12.78-18.400.00
Other Sources4.785.1631.9516.302.950.0021.430.000.00
Cash from Investing Activities-81.42-15.45-34.36179.11327.60184.08-668.54-261.24-2,460.68
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock68.35270.73283.2360.101.016.59304.9932.344,019.41
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock68.35270.73283.2360.101.016.59304.9932.344,019.41
Proceedsfrom Stock Options68.35270.73283.1560.100.792.150.940.883,968.38
Issuance or Reduction of Debt, Net29.67-17.77-159.29-377.9412.84-40.48651.40-75.29441.32
Change in Long Term Debt29.67-17.77-159.29-377.9412.84-40.48651.40-75.29441.32
Issuance of Long Term Debt143.58142.5048.500.00102.170.00663.2111.09444.89
Reduction of Long Term Debt-113.91-160.27-207.80-377.94-89.33-40.48-11.81-86.38-3.57
Net Financing Active Other Cash Flow-1.92-12.45-17.06-26.94-28.73-2.420.000.000.00
Other Financing Activities Uses-1.92-12.45-17.06-26.94-28.73-2.420.000.000.00
Cash from Financing Activities96.10240.51106.88-344.78-14.89-36.31956.39-42.954,460.74
Exchange Rate Effect4.062.626.03-0.9633.91-14.45-47.99-0.1553.03
Net Change in Cash-34.72181.52-40.61-375.66-74.83-301.98-112.31-884.941,645.24
Free Cash Flow-58.17-50.02-126.94-211.59-428.35-464.55-476.57-1,110.31-899.12
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.025.130.000.000.00-26.13-103.931.31

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments228.58240.83264.93274.56218.28109.53
Short Term Receivables26.1930.0226.0023.7419.3136.67
Inventories74.0275.7479.1977.0173.5868.76
Other Current Assets9.8410.319.277.469.257.36
Total Current Assets338.64356.91379.40382.76320.41222.32
Net Property, Plant & Equipment214.34219.35226.79207.94207.57213.47
Total Investments and Advances79.8788.4477.40113.19135.88118.65
Intangible Assets99.43101.61106.1290.2492.9996.52
Other Assets12.7811.7911.9412.8712.0412.04
Total Assets745.06778.09801.64807.00768.89663.01
Short Term Debt Incl. Current Port. of LT Debt40.4330.3521.909.3810.3913.87
Accounts Payable20.8220.1624.9514.5613.0317.65
Other Current Liabilities58.9167.0266.6847.7634.8640.80
Total Current Liabilities120.17117.54113.5371.7158.2972.31
Long Term Debt157.80165.12177.82176.74175.99226.37
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities4.615.585.88---
Other Liabilities4.434.484.555.445.645.97
Total Liabilities287.01292.71301.77253.89239.92304.65
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity458.05485.38499.87553.11528.97358.36
Total Shareholders Equity458.05485.38499.87553.11528.97358.36
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity458.05485.38499.87553.11528.97358.36
Total Liabilities & Stockholders Equity745.06778.09801.64807.00768.89663.01
Book Value Per Share1.081.151.181.501.591.75
Tangible Book Value Per Share0.850.910.931.261.311.28
Full-Time Employees--1,128---
Price to Book Ratio0.550.800.630.720.840.66
Return on Assets-26.07-23.51-26.25-28.51-32.45-45.91
Return on Equity-39.98-40.16-45.06-47.80-60.19-98.41
Return on Invested Capital-4.72-1.62-16.64-6.15-0.17-5.13
Quick Ratio2.202.392.644.264.232.12
Current Ratio2.823.043.345.345.503.07

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-28.95-10.53-115.79-44.53-1.36-29.99
Depreciation7.327.256.646.226.756.98
Other Funds (Non Cash)8.26-11.0881.6424.02-14.557.47
Funds from Operations-13.95-14.46-27.50-14.29-9.15-15.53
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital4.50-3.6113.652.18-3.948.07
Cash from Operating Activities-9.44-18.07-13.85-12.11-13.10-7.46
Capital Expenditures-3.54-0.53-0.87-1.33-1.07-1.08
Net Assets From Acquisitions0.000.00-30.280.000.000.00
Sale of Fixed Assets and Businesses1.080.000.000.00-0.000.00
Purchase or Sale of Investments-51.220.000.230.2712.790.56
Purchase of Investments-51.220.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.230.2712.790.56
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.084.690.420.00
Cash from Investing Activities-53.69-0.53-30.843.6412.14-0.51
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.004.4363.92176.7927.63
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.004.4363.92176.7927.63
Proceedsfrom Stock Options0.000.004.4363.92176.7927.63
Issuance or Reduction of Debt, Net-4.00-0.4733.490.64-51.37-0.66
Change in Long Term Debt-4.00-0.4733.490.64-51.37-0.66
Issuance of Long Term Debt0.000.00143.580.000.000.00
Reduction of Long Term Debt-4.00-0.47-110.090.64-51.37-0.66
Net Financing Active Other Cash Flow4.37-4.93-0.56-0.80-2.60-8.58
Other Financing Activities Uses4.37-4.93-0.56-0.80-2.60-8.58
Cash from Financing Activities0.37-5.3937.3663.76122.8218.39
Exchange Rate Effect-0.793.735.53-4.402.98-1.46
Net Change in Cash-63.55-20.27-1.7950.89124.848.95
Free Cash Flow-11.56-18.60-14.63-13.38-13.99-8.41

Revenue breakdown

Canada2024: 112.07M 2025: 134.68M
Germany2024: 43.06M 2025: 44.92M
Other Geographical Area2024: 12.36M 2025: 5.91M
United States2024: 25.87M 2025: 20.46M
Cannabis2024: 134.22M 2025: 154.83M
Storz Bickel2024: 59.14M 2025: 51.14M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.58%31.6M417.2M2.86M
2026-10-157.58%31.6M417.2M2.93M
2026-09-306.48%27.2M420.7M3.07M
2026-09-156.65%28.0M421.0M3.49M
2026-08-316.19%26.0M420.9M4.42M
2026-08-145.92%25.0M422.2M5.06M
2026-07-316.00%24.9M415.2M5.42M
2026-07-155.56%23.1M415.3M8.71M
2026-06-305.73%23.7M414.5M9.58M
2026-06-155.73%23.9M416.8M10.00M
2026-05-295.33%22.6M424.2M10.01M
2026-05-155.43%23.0M424.2M10.10M
2026-04-306.02%25.5M424.2M11.20M
2026-04-156.34%26.9M424.2M9.61M
2026-03-316.32%26.7M423.0M11.00M
2026-03-136.75%25.1M371.6M22.89M
2026-02-277.99%26.9M336.2M26.89M
2026-02-1310.18%34.2M336.2M28.97M
2026-01-3011.90%40.1M337.0M30.48M
2026-01-1510.51%35.4M337.0M31.19M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.090.120.013.5753921.000.849-0.0070.000
call1.000.000.010.015.0151,2470.000.110-0.0110.000
call1.500.000.010.017.3634.000.000.082-0.0120.000
call2.000.001.000.019.2272.000.000.071-0.0140.000
call3.000.000.500.0011.3820.000.000.062-0.0160.000
put0.500.000.010.023.4132891.00-0.202-0.0100.000
put1.000.380.410.425.0416790.00-0.890-0.0110.000
put1.500.411.410.8445.87416.000.00-0.918-0.0130.000
put2.000.901.901.3646.07111.000.00-0.929-0.0140.000
put3.001.892.892.4047.0755.000.00-0.938-0.0150.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-068-KCurrent report2026-11-06SEC
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-238-KCurrent report2026-10-23SEC
2026-10-16DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-10-168-KCurrent report2026-10-14SEC
2026-10-06DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-304Statement of changes in beneficial ownership of securities2026-09-28SEC
2026-09-25DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-09-174Statement of changes in beneficial ownership of securities2026-09-17SEC
2026-09-15DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-254Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-17DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-14DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-078-KCurrent report2026-08-07SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-07DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-08-07ARSAnnual report to security holders. 2026-03-31SEC
2026-08-07DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-25SEC
2026-08-078-KCurrent report2026-08-07SEC
2026-07-17PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-09-25SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-26SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-17SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090064.26K5
2026-080022.90K2
2026-070000
2026-0600238.99K7
2026-050000
2026-040000
2026-030028.58K4
2026-02009.95K1
2026-010000
2025-120029.55K2
2025-110000

Institutional holders

Manager% owned
Tidal Investments LLC2.20%
MORGAN STANLEY0.47%
LAZARD ASSET MANAGEMENT LLC0.44%
JANE STREET GROUP, LLC0.37%
GOLDMAN SACHS GROUP INC0.31%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.29%
ROYAL BANK OF CANADA0.26%
UBS Group AG0.26%
NATIONAL BANK OF CANADA /FI/0.21%
HRT FINANCIAL LP0.17%

Funds

Fund% owned
RiverPark Strategic Income Fund3.83%
Saba Capital Income & Opportunities Fund3.15%
Amplify Alternative Harvest ETF2.20%
Saba Capital Income & Opportunities Fund II2.00%
USA Mutuals Vice Fund0.07%
AdvisorShares Pure Cannabis ETF0.07%
State Street(R) SPDR(R) S&P(R) International Small Cap ETF0.03%
Lazard US Systematic Small Cap Equity ETF0.02%
INTERNATIONAL CORE EQUITY 2 PORTFOLIO0.01%
Avantis Emerging Markets Equity Fund0.01%

OakChart. CGC. Cached 15 minutes.